International Medical Director in Bleeding Disorders

Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger

Søborg

Are you a medical doctor with solid experience in clinical drug development? Are you passionate about bringing new treatments for patients living with Rare Bleeding Disorders?

Then, this is your chance. Apply now and join us to create life-changing innovation.

The position

You will be overall medically responsible for the clinical development strategy and execution for a clinical-stage asset for patients with Rare Bleeding Disorders.

The main areas of responsibility are:

  • Analyse and communicate data
  • Design clinical trials
  • Ensure medically sound regulatory interactions
  • Drive learnings one step further into innovative implementation and simple execution

The job is globally oriented and will require strong interactions with colleagues in regional offices as well as external stakeholders including regulatory bodies, treating physicians and therapeutic experts. You should have a flair for building and using both internal and external network(s) and share learnings actively within the project and department.

You will have a high degree of independence and teamwork where decisions have a high business impact. Therefore, focus as well as flexibility are important due to several tasks will be coming from different stakeholders, and expectation management is key to success.

You can expect travelling activities of approximately 15-20 days per year.

Qualifications

To thrive and succeed, we expect you to have:

  • University degree as a Medical Doctor
  • Strong experience with drug development and medical expertise in pharma/biotech industry
  • Proven track record in clinical trial design, execution, and reporting
  • PhD and clinical and/or drug development experience in haematology and especially in rare bleeding disorders is seen as an advantage
  • Proficient English

As a person, you are curious and a dedicated team player with strong analytical and communication skills. You come with a patient-centric mindset and a proactive attitude despite challenges.

About the Department

Medical & Science, Rare Disease is part of Clinical Drug Development. We are passionate on developing new treatments for rare blood and rare endocrine disorders and we span over various technologies such as proteins, small molecules, stem cells, gene therapy as platforms. In this role, you will be part of a team of highly qualified and motivated colleagues.

We are responsible for clinical development strategies and programmes of the Novo Nordisk portfolio including bridging the early ideas from research to the marketed products in life cycle management. Leveraging your clinical experience and expertise in drug development is pivotal for products to be developed and in the end, reach the patients to serve their needs.

The area consists of 3 departments with approximately 30 people including medical doctors (MDs) representing more than 13 different nationalities that form a strong basis for knowledge sharing and scientific discussions as well as a social and diverse environment.

Working at Novo Nordisk

At Novo Nordisk, we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing and sales – we’re all working to move the needle on patient care.

Contact

Katarina Cepo, Senior Medical Director, Medical & Science Rare Blood Disorders +45 30754637

Deadline

8 December 2022. We will screen applicants and conduct interviews on an ongoing basis, so we encourage you to apply as soon as possible.

To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV.

We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.

Print job Send to e-mail


Information og data

Denne ledige stilling har jobtypen "Forretningsudvikler", og befinder sig i kategorien "Kommunikation, marketing, salg".

Arbejdsstedet er beliggende i Søborg.

Jobbet er oprettet på vores service den 17.11.2022, men kan have været deaktiveret og genaktiveret igen.

Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
  • Forretningsudvikler
  • Søborg

Lignende jobs

Statistik over udbudte jobs som forretningsudviklere i Søborg

Herunder ser du udviklingen i udbudte forretningsudvikler i Søborg over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal forretningsudviklere.

Se flere statistikker her:
Statistik over udbudte forretningsudviklere i Søborg over tid

Dato Alle jobs som forretningsudviklere
22. november 2024 17
21. november 2024 17
20. november 2024 15
19. november 2024 12
18. november 2024 10
17. november 2024 10
16. november 2024 10
15. november 2024 10
14. november 2024 10
13. november 2024 9
12. november 2024 8
11. november 2024 8
10. november 2024 7
9. november 2024 7
8. november 2024 6
7. november 2024 6
6. november 2024 6
5. november 2024 6
4. november 2024 7
3. november 2024 6
2. november 2024 6
1. november 2024 6
31. oktober 2024 8
30. oktober 2024 7
29. oktober 2024 6
28. oktober 2024 6
27. oktober 2024 7
26. oktober 2024 7
25. oktober 2024 8
24. oktober 2024 8
23. oktober 2024 8